New arylsparteine derivatives as positive inotropic drugs.

about

C2-Modified Sparteine Derivatives Are a New Class of Potentially Long-Acting Sodium Channel Blockers.

P2860

Q47240571-6529D21E-D349-41A0-837B-86F123A89E32

P2860

New arylsparteine derivatives as positive inotropic drugs.

Item

http://www.wikidata.org/entity/Q53540568

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

New arylsparteine derivatives as positive inotropic drugs.

@en

New arylsparteine derivatives as positive inotropic drugs.

@nl

type

Item

label

New arylsparteine derivatives as positive inotropic drugs.

@en

New arylsparteine derivatives as positive inotropic drugs.

@nl

prefLabel

New arylsparteine derivatives as positive inotropic drugs.

@en

New arylsparteine derivatives as positive inotropic drugs.

@nl

P1476

New arylsparteine derivatives as positive inotropic drugs

@en

P2093

Bruno Tasso

http://www.w3.org/2001/XMLSchema#string

Elena Cichero

http://www.w3.org/2001/XMLSchema#string

Fabio Sparatore

http://www.w3.org/2001/XMLSchema#string

Federica Novelli

http://www.w3.org/2001/XMLSchema#string

Guglielmina Froldi

http://www.w3.org/2001/XMLSchema#string

Marcella Ercoli

http://www.w3.org/2001/XMLSchema#string

Paola Dorigo

http://www.w3.org/2001/XMLSchema#string

Paola Fossa

http://www.w3.org/2001/XMLSchema#string

Vito Boido

http://www.w3.org/2001/XMLSchema#string

P2860

Use of Inotropic Agents in Treatment of Systolic Heart Failure

New therapeutic targets for the development of positive inotropic agents

Inotropes.

Crystal structure of the human σ1 receptor

Sigma receptors: from discovery to highlights of their implications in the cardiovascular system

sigma Receptor activation blocks potassium channels and depresses neuroexcitability in rat intracardiac neurons

Pharmacophore identification for sigma-1 (sigma1) receptor binding: application of the "deconstruction-reconstruction-elaboration" approach.

Targeting sigma-1 receptor signaling by endogenous ligands for cardioprotection.

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the

Cytisine derivatives as ligands for neuronal nicotine receptors and with various pharmacological activities.

P304

588-599

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14756366.2017.1279156

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Michele Tonelli

P577

2017-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28133984

http://www.w3.org/2001/XMLSchema#string

P932

6009970

http://www.w3.org/2001/XMLSchema#string

New arylsparteine derivatives as positive inotropic drugs.

about

P2860

P2860

New arylsparteine derivatives as positive inotropic drugs.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932